Eli Lilly Announces Covered Entities Must Submit Claims Data for All of Its Products

1/16/2026 – Eli Lilly Announces Covered Entities Must Submit Claims Data for All of Its Products Pharmaceutical manufacturer Eli Lilly announced that, effective February 1, all covered entities must submit claims-level…

Response to 340B ACCESS Act Sign-on Letter

01/16/2025 – Response to 340B ACCESS Act Sign-on Letter Several patient and provider organizations sent a letter to the House Energy and Commerce committee in October 2025 supporting legislation opposed…

First Circuit Reaffirms Rebate Pilot Pause; CMS Proposes Models Requiring Drug Manufacturers to Pay Additional Rebates on Medicare Drugs if the Net Prices Under the IRA Exceed Prices in Similar Countries

1/8/2026 – First Circuit Reaffirms Rebate Pilot Pause; CMS Proposes Models Requiring Drug Manufacturers to Pay Additional Rebates on Medicare Drugs if the Net Prices Under the IRA Exceed Prices…

Rebate Pilot Litigation Update: Parties Agree to “Drop” Appeal

1/12/2025 – Rebate Pilot Litigation Update: Parties Agree to “Drop” Appeal This morning, DOJ filed a letter with the First Circuit Court of Appeals (First Circuit) stating that the government and hospital plaintiffs…

HRSA Confirms Suspension of Rebate Pilot

12/31/2025 – HRSA Confirms Suspension of Rebate Pilot Today, HRSA updated its website to confirm that its controversial 340B rebate model pilot program (rebate pilot) is suspended. HRSA states that…